제논 파머슈티컬(XENE)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $39.75 (-30.69%), 시가총액 $5.26B, 52주 범위 $28.49 ~ $62.76.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product candidates include Azetukalner, a novel, potent Kv7 potassium channel opener which is in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression.
제논 파머슈티컬의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
제논 파머슈티컬의 현재 주가는 $39.75 (-30.69%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
제논 파머슈티컬의 시가총액은 약 $5.26B입니다.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric…